<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2006-11-28" modified="2020-08-12" version="162">
<accession>Q16526</accession>
<name>CRY1_HUMAN</name>
<protein>
<recommendedName>
<fullName>Cryptochrome-1</fullName>
</recommendedName>
</protein>
<gene>
<name type="primary">CRY1</name>
<name type="synonym">PHLL1</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1996" name="Biochemistry" volume="35" first="13871" last="13877">
<title>Putative human blue-light photoreceptors hCRY1 and hCRY2 are flavoproteins.</title>
<authorList>
<person name="Hsu D.S."/>
<person name="Zhao X."/>
<person name="Zhao S."/>
<person name="Kazantsev A."/>
<person name="Wang R.-P."/>
<person name="Todo T."/>
<person name="Wei Y.-F."/>
<person name="Sancar A."/>
</authorList>
<dbReference type="PubMed" id="8909283"/>
<dbReference type="DOI" id="10.1021/bi962209o"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>CHARACTERIZATION</scope>
<source>
<tissue>Fibroblast</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1996" name="Genomics" volume="37" first="177" last="182">
<title>Cloning, tissue expression, and mapping of a human photolyase homolog with similarity to plant blue-light receptors.</title>
<authorList>
<person name="van der Spek P.J."/>
<person name="Kobayashi K."/>
<person name="Bootsma D."/>
<person name="Takao M."/>
<person name="Eker A.P.M."/>
<person name="Yasui A."/>
</authorList>
<dbReference type="PubMed" id="8921389"/>
<dbReference type="DOI" id="10.1006/geno.1996.0539"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="1996" name="Science" volume="272" first="109" last="112">
<title>Similarity among the Drosophila (6-4)photolyase, a human photolyase homolog, and the DNA photolyase-blue-light photoreceptor family.</title>
<authorList>
<person name="Todo T."/>
<person name="Ryo H."/>
<person name="Yamamoto K."/>
<person name="Toh H."/>
<person name="Inui T."/>
<person name="Ayaki H."/>
<person name="Nomura T."/>
<person name="Ikenaga M."/>
</authorList>
<dbReference type="PubMed" id="8600518"/>
<dbReference type="DOI" id="10.1126/science.272.5258.109"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="1999" name="Science" volume="286" first="768" last="771">
<title>Light-independent role of CRY1 and CRY2 in the mammalian circadian clock.</title>
<authorList>
<person name="Griffin E.A. Jr."/>
<person name="Staknis D."/>
<person name="Weitz C.J."/>
</authorList>
<dbReference type="PubMed" id="10531061"/>
<dbReference type="DOI" id="10.1126/science.286.5440.768"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Biochem. Biophys. Res. Commun." volume="313" first="117" last="124">
<title>A novel autofeedback loop of Dec1 transcription involved in circadian rhythm regulation.</title>
<authorList>
<person name="Kawamoto T."/>
<person name="Noshiro M."/>
<person name="Sato F."/>
<person name="Maemura K."/>
<person name="Takeda N."/>
<person name="Nagai R."/>
<person name="Iwata T."/>
<person name="Fujimoto K."/>
<person name="Furukawa M."/>
<person name="Miyazaki K."/>
<person name="Honma S."/>
<person name="Honma K.I."/>
<person name="Kato Y."/>
</authorList>
<dbReference type="PubMed" id="14672706"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2003.11.099"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2006" name="Proc. Natl. Acad. Sci. U.S.A." volume="103" first="10467" last="10472">
<title>Posttranslational regulation of the mammalian circadian clock by cryptochrome and protein phosphatase 5.</title>
<authorList>
<person name="Partch C.L."/>
<person name="Shields K.F."/>
<person name="Thompson C.L."/>
<person name="Selby C.P."/>
<person name="Sancar A."/>
</authorList>
<dbReference type="PubMed" id="16790549"/>
<dbReference type="DOI" id="10.1073/pnas.0604138103"/>
</citation>
<scope>INTERACTION WITH PPP5C</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2007" name="Science" volume="316" first="900" last="904">
<title>SCFFbxl3 controls the oscillation of the circadian clock by directing the degradation of cryptochrome proteins.</title>
<authorList>
<person name="Busino L."/>
<person name="Bassermann F."/>
<person name="Maiolica A."/>
<person name="Lee C."/>
<person name="Nolan P.M."/>
<person name="Godinho S.I."/>
<person name="Draetta G.F."/>
<person name="Pagano M."/>
</authorList>
<dbReference type="PubMed" id="17463251"/>
<dbReference type="DOI" id="10.1126/science.1141194"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>UBIQUITINATION BY FBXL3</scope>
<scope>INTERACTION WITH FBXL3</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2010" name="Nat. Med." volume="16" first="1152" last="1156">
<title>Cryptochrome mediates circadian regulation of cAMP signaling and hepatic gluconeogenesis.</title>
<authorList>
<person name="Zhang E.E."/>
<person name="Liu Y."/>
<person name="Dentin R."/>
<person name="Pongsawakul P.Y."/>
<person name="Liu A.C."/>
<person name="Hirota T."/>
<person name="Nusinow D.A."/>
<person name="Sun X."/>
<person name="Landais S."/>
<person name="Kodama Y."/>
<person name="Brenner D.A."/>
<person name="Montminy M."/>
<person name="Kay S.A."/>
</authorList>
<dbReference type="PubMed" id="20852621"/>
<dbReference type="DOI" id="10.1038/nm.2214"/>
</citation>
<scope>INTERACTION WITH GNAS</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2011" name="J. Biol. Chem." volume="286" first="25891" last="25902">
<title>Biochemical analysis of the canonical model for the mammalian circadian clock.</title>
<authorList>
<person name="Ye R."/>
<person name="Selby C.P."/>
<person name="Ozturk N."/>
<person name="Annayev Y."/>
<person name="Sancar A."/>
</authorList>
<dbReference type="PubMed" id="21613214"/>
<dbReference type="DOI" id="10.1074/jbc.m111.254680"/>
</citation>
<scope>INTERACTION WITH PER2</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2011" name="Nature" volume="480" first="552" last="556">
<title>Cryptochromes mediate rhythmic repression of the glucocorticoid receptor.</title>
<authorList>
<person name="Lamia K.A."/>
<person name="Papp S.J."/>
<person name="Yu R.T."/>
<person name="Barish G.D."/>
<person name="Uhlenhaut N.H."/>
<person name="Jonker J.W."/>
<person name="Downes M."/>
<person name="Evans R.M."/>
</authorList>
<dbReference type="PubMed" id="22170608"/>
<dbReference type="DOI" id="10.1038/nature10700"/>
</citation>
<scope>FUNCTION AS NR3C1 REPRESSOR</scope>
<scope>INTERACTION WITH AR; NR1D1; NR3C1; RORA AND RORC</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2012" name="PLoS ONE" volume="7" first="E48152" last="E48152">
<title>Role of type II protein arginine methyltransferase 5 in the regulation of Circadian Per1 gene.</title>
<authorList>
<person name="Na J."/>
<person name="Lee K."/>
<person name="Kim H.G."/>
<person name="Shin J.Y."/>
<person name="Na W."/>
<person name="Jeong H."/>
<person name="Lee J.W."/>
<person name="Cho S."/>
<person name="Kim W.S."/>
<person name="Ju B.G."/>
</authorList>
<dbReference type="PubMed" id="23133559"/>
<dbReference type="DOI" id="10.1371/journal.pone.0048152"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH PRMT5</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2012" name="Science" volume="337" first="1094" last="1097">
<title>Identification of small molecule activators of cryptochrome.</title>
<authorList>
<person name="Hirota T."/>
<person name="Lee J.W."/>
<person name="St John P.C."/>
<person name="Sawa M."/>
<person name="Iwaisako K."/>
<person name="Noguchi T."/>
<person name="Pongsawakul P.Y."/>
<person name="Sonntag T."/>
<person name="Welsh D.K."/>
<person name="Brenner D.A."/>
<person name="Doyle F.J. III"/>
<person name="Schultz P.G."/>
<person name="Kay S.A."/>
</authorList>
<dbReference type="PubMed" id="22798407"/>
<dbReference type="DOI" id="10.1126/science.1223710"/>
</citation>
<scope>ACTIVITY REGULATION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>UBIQUITINATION</scope>
<scope>MUTAGENESIS OF ASP-387 AND ASN-393</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2013" name="Physiol. Rev." volume="93" first="107" last="135">
<title>Metabolism and the circadian clock converge.</title>
<authorList>
<person name="Eckel-Mahan K."/>
<person name="Sassone-Corsi P."/>
</authorList>
<dbReference type="PubMed" id="23303907"/>
<dbReference type="DOI" id="10.1152/physrev.00016.2012"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2014" name="Trends Cell Biol." volume="24" first="90" last="99">
<title>Molecular architecture of the mammalian circadian clock.</title>
<authorList>
<person name="Partch C.L."/>
<person name="Green C.B."/>
<person name="Takahashi J.S."/>
</authorList>
<dbReference type="PubMed" id="23916625"/>
<dbReference type="DOI" id="10.1016/j.tcb.2013.07.002"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2015" name="PLoS ONE" volume="10" first="E0139725" last="E0139725">
<title>CUL4-DDB1-CDT2 E3 ligase regulates the molecular clock activity by promoting ubiquitination-dependent degradation of the mammalian CRY1.</title>
<authorList>
<person name="Tong X."/>
<person name="Zhang D."/>
<person name="Guha A."/>
<person name="Arthurs B."/>
<person name="Cazares V."/>
<person name="Gupta N."/>
<person name="Yin L."/>
</authorList>
<dbReference type="PubMed" id="26431207"/>
<dbReference type="DOI" id="10.1371/journal.pone.0139725"/>
</citation>
<scope>INTERACTION WITH DDB1-CUE4A COMPLEX AND DTL</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2016" name="Cell" volume="166" first="1198" last="1214">
<title>Two distinct types of E3 ligases work in unison to regulate substrate ubiquitylation.</title>
<authorList>
<person name="Scott D.C."/>
<person name="Rhee D.Y."/>
<person name="Duda D.M."/>
<person name="Kelsall I.R."/>
<person name="Olszewski J.L."/>
<person name="Paulo J.A."/>
<person name="de Jong A."/>
<person name="Ovaa H."/>
<person name="Alpi A.F."/>
<person name="Harper J.W."/>
<person name="Schulman B.A."/>
</authorList>
<dbReference type="PubMed" id="27565346"/>
<dbReference type="DOI" id="10.1016/j.cell.2016.07.027"/>
</citation>
<scope>UBIQUITINATION</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2017" name="Cell" volume="169" first="203" last="215">
<title>Mutation of the human circadian clock gene CRY1 in familial delayed sleep phase disorder.</title>
<authorList>
<person name="Patke A."/>
<person name="Murphy P.J."/>
<person name="Onat O.E."/>
<person name="Krieger A.C."/>
<person name="Oezcelik T."/>
<person name="Campbell S.S."/>
<person name="Young M.W."/>
</authorList>
<dbReference type="PubMed" id="28388406"/>
<dbReference type="DOI" id="10.1016/j.cell.2017.03.027"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH CLOCK-ARNTL</scope>
<scope>INVOLVEMENT IN DSPS</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2018" name="Proc. Natl. Acad. Sci. U.S.A." volume="115" first="E12305" last="E12312">
<title>Nuclear receptor HNF4A transrepresses CLOCK:BMAL1 and modulates tissue-specific circadian networks.</title>
<authorList>
<person name="Qu M."/>
<person name="Duffy T."/>
<person name="Hirota T."/>
<person name="Kay S.A."/>
</authorList>
<dbReference type="PubMed" id="30530698"/>
<dbReference type="DOI" id="10.1073/pnas.1816411115"/>
</citation>
<scope>INTERACTION WITH HNF4A</scope>
</reference>
<comment type="function">
<text evidence="1 2 3 8 10 13">Transcriptional repressor which forms a core component of the circadian clock. The circadian clock, an internal time-keeping system, regulates various physiological processes through the generation of approximately 24 hour circadian rhythms in gene expression, which are translated into rhythms in metabolism and behavior. It is derived from the Latin roots 'circa' (about) and 'diem' (day) and acts as an important regulator of a wide array of physiological functions including metabolism, sleep, body temperature, blood pressure, endocrine, immune, cardiovascular, and renal function. Consists of two major components: the central clock, residing in the suprachiasmatic nucleus (SCN) of the brain, and the peripheral clocks that are present in nearly every tissue and organ system. Both the central and peripheral clocks can be reset by environmental cues, also known as Zeitgebers (German for 'timegivers'). The predominant Zeitgeber for the central clock is light, which is sensed by retina and signals directly to the SCN. The central clock entrains the peripheral clocks through neuronal and hormonal signals, body temperature and feeding-related cues, aligning all clocks with the external light/dark cycle. Circadian rhythms allow an organism to achieve temporal homeostasis with its environment at the molecular level by regulating gene expression to create a peak of protein expression once every 24 hours to control when a particular physiological process is most active with respect to the solar day. Transcription and translation of core clock components (CLOCK, NPAS2, ARNTL/BMAL1, ARNTL2/BMAL2, PER1, PER2, PER3, CRY1 and CRY2) plays a critical role in rhythm generation, whereas delays imposed by post-translational modifications (PTMs) are important for determining the period (tau) of the rhythms (tau refers to the period of a rhythm and is the length, in time, of one complete cycle). A diurnal rhythm is synchronized with the day/night cycle, while the ultradian and infradian rhythms have a period shorter and longer than 24 hours, respectively. Disruptions in the circadian rhythms contribute to the pathology of cardiovascular diseases, cancer, metabolic syndromes and aging. A transcription/translation feedback loop (TTFL) forms the core of the molecular circadian clock mechanism. Transcription factors, CLOCK or NPAS2 and ARNTL/BMAL1 or ARNTL2/BMAL2, form the positive limb of the feedback loop, act in the form of a heterodimer and activate the transcription of core clock genes and clock-controlled genes (involved in key metabolic processes), harboring E-box elements (5'-CACGTG-3') within their promoters. The core clock genes: PER1/2/3 and CRY1/2 which are transcriptional repressors form the negative limb of the feedback loop and interact with the CLOCK|NPAS2-ARNTL/BMAL1|ARNTL2/BMAL2 heterodimer inhibiting its activity and thereby negatively regulating their own expression. This heterodimer also activates nuclear receptors NR1D1/2 and RORA/B/G, which form a second feedback loop and which activate and repress ARNTL/BMAL1 transcription, respectively. CRY1 and CRY2 have redundant functions but also differential and selective contributions at least in defining the pace of the SCN circadian clock and its circadian transcriptional outputs. More potent transcriptional repressor in cerebellum and liver than CRY2, though more effective in lengthening the period of the SCN oscillator. On its side, CRY2 seems to play a critical role in tuning SCN circadian period by opposing the action of CRY1. With CRY2, is dispensable for circadian rhythm generation but necessary for the development of intercellular networks for rhythm synchrony. Capable of translocating circadian clock core proteins such as PER proteins to the nucleus. Interacts with CLOCK-ARNTL/BMAL1 independently of PER proteins and is found at CLOCK-ARNTL/BMAL1-bound sites, suggesting that CRY may act as a molecular gatekeeper to maintain CLOCK-ARNTL/BMAL1 in a poised and repressed state until the proper time for transcriptional activation. Represses the CLOCK-ARNTL/BMAL1 induced transcription of BHLHE40/DEC1. Represses the CLOCK-ARNTL/BMAL1 induced transcription of ATF4, MTA1, KLF10 and NAMPT (By similarity). May repress circadian target genes expression in collaboration with HDAC1 and HDAC2 through histone deacetylation. Mediates the clock-control activation of ATR and modulates ATR-mediated DNA damage checkpoint. In liver, mediates circadian regulation of cAMP signaling and gluconeogenesis by binding to membrane-coupled G proteins and blocking glucagon-mediated increases in intracellular cAMP concentrations and CREB1 phosphorylation. Inhibits hepatic gluconeogenesis by decreasing nuclear FOXO1 levels that downregulates gluconeogenic gene expression (By similarity). Besides its role in the maintenance of the circadian clock, is also involved in the regulation of other processes. Represses glucocorticoid receptor NR3C1/GR-induced transcriptional activity by binding to glucocorticoid response elements (GREs). Plays a key role in glucose and lipid metabolism modulation, in part, through the transcriptional regulation of genes involved in these pathways, such as LEP or ACSL4 (By similarity). Represses PPARD and its target genes in the skeletal muscle and limits exercise capacity (By similarity). Plays an essential role in the generation of circadian rhythms in the retina (By similarity). Represses the transcriptional activity of NR1I2 (By similarity).</text>
</comment>
<comment type="cofactor">
<cofactor evidence="1">
<name>FAD</name>
<dbReference type="ChEBI" id="CHEBI:57692"/>
</cofactor>
<text evidence="1">Binds 1 FAD per subunit. Only a minority of the protein molecules contain bound FAD. Contrary to the situation in photolyases, the FAD is bound in a shallow, surface-exposed pocket.</text>
</comment>
<comment type="cofactor">
<cofactor>
<name>(6R)-5,10-methylene-5,6,7,8-tetrahydrofolate</name>
<dbReference type="ChEBI" id="CHEBI:15636"/>
</cofactor>
<text>Binds 1 5,10-methenyltetrahydrofolate (MTHF) non-covalently per subunit.</text>
</comment>
<comment type="activity regulation">
<text evidence="9">KL001 (N-[3-(9H-carbazol-9-yl)-2-hydroxypropyl]-N-(2-furanylmethyl)-methanesulfonamide) binds to CRY1 and stabilizes it by inhibiting FBXL3- and ubiquitin-dependent degradation of CRY1 resulting in lengthening of the circadian periods.</text>
</comment>
<comment type="subunit">
<text evidence="1 4 5 6 7 8 10 11 13 14">Component of the circadian core oscillator, which includes the CRY proteins, CLOCK or NPAS2, ARNTL/BMAL1 or ARNTL2/BMAL2, CSNK1D and/or CSNK1E, TIMELESS, and the PER proteins (By similarity). Interacts directly with TIMELESS (By similarity). Interacts directly with PER1 and PER3 (By similarity). Interacts directly with PER2; interaction with PER2 inhibits its ubiquitination and vice versa (PubMed:21613214). Interacts with FBXL21 (By similarity). Interacts with FBXL3 (PubMed:17463251). Interacts with PPP5C (via TPR repeats) (PubMed:16790549). Interacts with CLOCK-ARNTL/BMAL1 independently of PER2 and DNA (PubMed:28388406). Interacts with HDAC1, HDAC2 and SIN3B. Interacts with nuclear receptors AR, NR1D1, NR3C1/GR, RORA and RORC; the interaction with at least NR3C1/GR is ligand dependent (PubMed:22170608). Interacts with PRKDC (By similarity). Interacts with the G protein subunit alpha GNAS; the interaction may block GPCR-mediated regulation of cAMP concentrations (PubMed:20852621). Interacts with PRMT5 (PubMed:23133559). Interacts with EZH2 (By similarity). Interacts with MYBBP1A, DOCK7, HNRNPU, RPL7A, RPL8 and RPS3 (By similarity). Interacts with MAP1LC3B (By similarity). Interacts with CLOCK (By similarity). Interacts with ARNTL/BMAL1 (By similarity). Interacts weakly with HDAC3; this interaction is enhanced in the presence of FBXL3 (By similarity). Interacts with TRIM28, KCTD5 and DDB1 (By similarity). Interacts with FOXO1 (By similarity). Interacts with DTL and DDB1-CUL4A complex (PubMed:26431207). Interacts with HNF4A (PubMed:30530698). Interacts with PSMD2 in a KDM8-dependent manner (By similarity). Interacts with KDM8 in a FBXL3-dependent manner (By similarity). Interacts with PPARG in a ligand-dependent manner (By similarity). Interacts with PPARD (via domain NR LBD) and NR1I2 (via domain NR LBD) in a ligand-dependent manner (By similarity). Interacts with PPARA, NR1I3 and VDR (By similarity).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-741297">
<id>Q16526</id>
</interactant>
<interactant intactId="EBI-351098">
<id>O14744</id>
<label>PRMT5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="9 11 13">Nucleus</location>
</subcellularLocation>
<text evidence="1">Translocated to the nucleus through interaction with other clock proteins such as PER2 or ARNTL/BMAL1.</text>
</comment>
<comment type="induction">
<text>Expression is regulated by light and circadian rhythms and osicllates diurnally. Peak expression in the suprachiasma nucleus (SCN) and eye at the day/night transition (CT12). Levels decrease with ARNTL/BMAL1-CLOCK inhibition as part of the autoregulatory feedback loop.</text>
</comment>
<comment type="domain">
<text evidence="1">The LIR motifs (LC3-interacting region) 3 and 5 are required for its interaction with MAP1LC3B and for its autophagy-mediated degradation.</text>
</comment>
<comment type="PTM">
<text evidence="1">Phosphorylation on Ser-247 by MAPK is important for the inhibition of CLOCK-ARNTL/BMAL1-mediated transcriptional activity. Phosphorylation by CSNK1E requires interaction with PER1 or PER2. Phosphorylation at Ser-71 and Ser-280 by AMPK decreases protein stability. Phosphorylation at Ser-568 exhibits a robust circadian rhythm with a peak at CT8, increases protein stability, prevents SCF(FBXL3)-mediated degradation and is antagonized by interaction with PRKDC.</text>
</comment>
<comment type="PTM">
<text evidence="1 5 9 12">Ubiquitinated by the SCF(FBXL3) and SCF(FBXL21) complexes, regulating the balance between degradation and stabilization. The SCF(FBXL3) complex is mainly nuclear and mediates ubiquitination and subsequent degradation of CRY1. In contrast, cytoplasmic SCF(FBXL21) complex-mediated ubiquitination leads to stabilize CRY1 and counteract the activity of the SCF(FBXL3) complex. The SCF(FBXL3) and SCF(FBXL21) complexes probably mediate ubiquitination at different Lys residues. Ubiquitination at Lys-11 and Lys-107 are specifically ubiquitinated by the SCF(FBXL21) complex but not by the SCF(FBXL3) complex. Ubiquitination may be inhibited by PER2 (PubMed:17463251, PubMed:22798407, PubMed:27565346). Deubiquitinated by USP7 (By similarity).</text>
</comment>
<comment type="PTM">
<text evidence="1">Undergoes autophagy-mediated degradation in the liver in a time-dependent manner. Autophagic degradation of CRY1 (an inhibitor of gluconeogenesis) occurs during periods of reduced feeding allowing induction of gluconeogenesis and maintenance of blood glucose levels.</text>
</comment>
<comment type="disease" evidence="13">
<disease id="DI-03211">
<name>Delayed sleep phase syndrome</name>
<acronym>DSPS</acronym>
<description>A circadian rhythm sleep disorder characterized by sleep-onset insomnia and difficulty in awakening at the desired time. Patients with DSPS have chronic difficulty in adjusting their sleep-onset and wake-up times to occupational, school, and social activities.</description>
<dbReference type="MIM" id="614163"/>
</disease>
<text evidence="13">Disease susceptibility is associated with variations affecting the gene represented in this entry. An adenine-to-cytosine transversion within the 5'splice site following exon 11 has been found in multiple members of a DSPD family and segregates with the disorder with autosomal dominant inheritance pattern. This variant is predicted to cause exon 11 skipping and in-frame deletion of 24 residues in the C-terminal region of CRY1. Functional studies show that the mutated protein acts as a more potent transcriptional repressor than wild-type, causes reduced expression of key transcriptional targets and lengthens the period of circadian molecular rhythms.</text>
</comment>
<comment type="similarity">
<text evidence="15">Belongs to the DNA photolyase class-1 family.</text>
</comment>
<comment type="online information" name="Wikipedia">
<link uri="https://en.wikipedia.org/wiki/Cryptochrome"/>
<text>Cryptochrome entry</text>
</comment>
<dbReference type="EMBL" id="D84657">
<property type="protein sequence ID" value="BAA12710.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="D83702">
<property type="protein sequence ID" value="BAA12068.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC030519">
<property type="protein sequence ID" value="AAH30519.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS9112.1"/>
<dbReference type="RefSeq" id="NP_004066.1">
<property type="nucleotide sequence ID" value="NM_004075.4"/>
</dbReference>
<dbReference type="SMR" id="Q16526"/>
<dbReference type="BioGRID" id="107797">
<property type="interactions" value="150"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-3219">
<property type="entry name" value="Cry1-Per2 complex"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-3222">
<property type="entry name" value="Cry1-Per1 complex"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-3223">
<property type="entry name" value="Cry1-Per3 complex"/>
</dbReference>
<dbReference type="CORUM" id="Q16526"/>
<dbReference type="DIP" id="DIP-56602N"/>
<dbReference type="IntAct" id="Q16526">
<property type="interactions" value="127"/>
</dbReference>
<dbReference type="STRING" id="9606.ENSP00000008527"/>
<dbReference type="GuidetoPHARMACOLOGY" id="2876"/>
<dbReference type="iPTMnet" id="Q16526"/>
<dbReference type="PhosphoSitePlus" id="Q16526"/>
<dbReference type="BioMuta" id="CRY1"/>
<dbReference type="DMDM" id="74735764"/>
<dbReference type="EPD" id="Q16526"/>
<dbReference type="jPOST" id="Q16526"/>
<dbReference type="MassIVE" id="Q16526"/>
<dbReference type="MaxQB" id="Q16526"/>
<dbReference type="PaxDb" id="Q16526"/>
<dbReference type="PeptideAtlas" id="Q16526"/>
<dbReference type="PRIDE" id="Q16526"/>
<dbReference type="ProteomicsDB" id="60893"/>
<dbReference type="Antibodypedia" id="3122">
<property type="antibodies" value="278 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="1407"/>
<dbReference type="Ensembl" id="ENST00000008527">
<property type="protein sequence ID" value="ENSP00000008527"/>
<property type="gene ID" value="ENSG00000008405"/>
</dbReference>
<dbReference type="GeneID" id="1407"/>
<dbReference type="KEGG" id="hsa:1407"/>
<dbReference type="UCSC" id="uc001tmi.5">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="1407"/>
<dbReference type="DisGeNET" id="1407"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000008405.11"/>
<dbReference type="GeneCards" id="CRY1"/>
<dbReference type="HGNC" id="HGNC:2384">
<property type="gene designation" value="CRY1"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000008405">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MIM" id="601933">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="614163">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q16526"/>
<dbReference type="OpenTargets" id="ENSG00000008405"/>
<dbReference type="PharmGKB" id="PA26904"/>
<dbReference type="eggNOG" id="KOG0133">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000155455"/>
<dbReference type="HOGENOM" id="CLU_010348_3_4_1"/>
<dbReference type="InParanoid" id="Q16526"/>
<dbReference type="KO" id="K02295"/>
<dbReference type="OMA" id="WQWSASS"/>
<dbReference type="OrthoDB" id="378952at2759"/>
<dbReference type="PhylomeDB" id="Q16526"/>
<dbReference type="TreeFam" id="TF323191"/>
<dbReference type="PathwayCommons" id="Q16526"/>
<dbReference type="Reactome" id="R-HSA-400253">
<property type="pathway name" value="Circadian Clock"/>
</dbReference>
<dbReference type="SIGNOR" id="Q16526"/>
<dbReference type="BioGRID-ORCS" id="1407">
<property type="hits" value="3 hits in 876 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="CRY1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GenomeRNAi" id="1407"/>
<dbReference type="Pharos" id="Q16526">
<property type="development level" value="Tchem"/>
</dbReference>
<dbReference type="PRO" id="PR:Q16526"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 12"/>
</dbReference>
<dbReference type="RNAct" id="Q16526">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000008405">
<property type="expression patterns" value="Expressed in oocyte and 245 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q16526">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q16526">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005739">
<property type="term" value="C:mitochondrion"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0009882">
<property type="term" value="F:blue light photoreceptor activity"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003677">
<property type="term" value="F:DNA binding"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0003690">
<property type="term" value="F:double-stranded DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070888">
<property type="term" value="F:E-box binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042826">
<property type="term" value="F:histone deacetylase binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0035257">
<property type="term" value="F:nuclear hormone receptor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000166">
<property type="term" value="F:nucleotide binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0019902">
<property type="term" value="F:phosphatase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019901">
<property type="term" value="F:protein kinase binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0009785">
<property type="term" value="P:blue light signaling pathway"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032922">
<property type="term" value="P:circadian regulation of gene expression"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007623">
<property type="term" value="P:circadian rhythm"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006975">
<property type="term" value="P:DNA damage induced protein phosphorylation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043153">
<property type="term" value="P:entrainment of circadian clock by photoperiod"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006094">
<property type="term" value="P:gluconeogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042593">
<property type="term" value="P:glucose homeostasis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019915">
<property type="term" value="P:lipid storage"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042754">
<property type="term" value="P:negative regulation of circadian rhythm"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045744">
<property type="term" value="P:negative regulation of G protein-coupled receptor signaling pathway"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000323">
<property type="term" value="P:negative regulation of glucocorticoid receptor signaling pathway"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000850">
<property type="term" value="P:negative regulation of glucocorticoid secretion"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045721">
<property type="term" value="P:negative regulation of gluconeogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031397">
<property type="term" value="P:negative regulation of protein ubiquitination"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000122">
<property type="term" value="P:negative regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045892">
<property type="term" value="P:negative regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031398">
<property type="term" value="P:positive regulation of protein ubiquitination"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0018298">
<property type="term" value="P:protein-chromophore linkage"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0042752">
<property type="term" value="P:regulation of circadian rhythm"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000001">
<property type="term" value="P:regulation of DNA damage checkpoint"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0014823">
<property type="term" value="P:response to activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0033762">
<property type="term" value="P:response to glucagon"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032868">
<property type="term" value="P:response to insulin"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0009416">
<property type="term" value="P:response to light stimulus"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.50.620">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR036134">
<property type="entry name" value="Crypto/Photolyase_FAD-like_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR036155">
<property type="entry name" value="Crypto/Photolyase_N_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR005101">
<property type="entry name" value="Cryptochr/Photolyase_FAD-bd"/>
</dbReference>
<dbReference type="InterPro" id="IPR006050">
<property type="entry name" value="DNA_photolyase_N"/>
</dbReference>
<dbReference type="InterPro" id="IPR014729">
<property type="entry name" value="Rossmann-like_a/b/a_fold"/>
</dbReference>
<dbReference type="Pfam" id="PF00875">
<property type="entry name" value="DNA_photolyase"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF03441">
<property type="entry name" value="FAD_binding_7"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48173">
<property type="entry name" value="SSF48173"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52425">
<property type="entry name" value="SSF52425"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51645">
<property type="entry name" value="PHR_CRY_ALPHA_BETA"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0090">Biological rhythms</keyword>
<keyword id="KW-0157">Chromophore</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0274">FAD</keyword>
<keyword id="KW-0285">Flavoprotein</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0600">Photoreceptor protein</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0678">Repressor</keyword>
<keyword id="KW-0716">Sensory transduction</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="Cryptochrome-1" id="PRO_0000261140">
<location>
<begin position="1"/>
<end position="586"/>
</location>
</feature>
<feature type="domain" description="Photolyase/cryptochrome alpha/beta">
<location>
<begin position="3"/>
<end position="132"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="FAD" evidence="1">
<location>
<begin position="387"/>
<end position="389"/>
</location>
</feature>
<feature type="region of interest" description="Required for inhibition of CLOCK-ARNTL/BMAL1-mediated transcription" evidence="1">
<location>
<begin position="371"/>
<end position="470"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with TIMELESS" evidence="1">
<location>
<begin position="471"/>
<end position="493"/>
</location>
</feature>
<feature type="short sequence motif" description="LIR 1" evidence="1">
<location>
<begin position="50"/>
<end position="54"/>
</location>
</feature>
<feature type="short sequence motif" description="LIR 2" evidence="1">
<location>
<begin position="82"/>
<end position="87"/>
</location>
</feature>
<feature type="short sequence motif" description="LIR 3" evidence="1">
<location>
<begin position="151"/>
<end position="156"/>
</location>
</feature>
<feature type="short sequence motif" description="LIR 4" evidence="1">
<location>
<begin position="255"/>
<end position="260"/>
</location>
</feature>
<feature type="short sequence motif" description="LIR 5" evidence="1">
<location>
<begin position="271"/>
<end position="276"/>
</location>
</feature>
<feature type="short sequence motif" description="LIR 6" evidence="1">
<location>
<begin position="285"/>
<end position="290"/>
</location>
</feature>
<feature type="short sequence motif" description="LIR 7" evidence="1">
<location>
<begin position="335"/>
<end position="339"/>
</location>
</feature>
<feature type="short sequence motif" description="LIR 8" evidence="1">
<location>
<begin position="379"/>
<end position="384"/>
</location>
</feature>
<feature type="short sequence motif" description="LIR 9" evidence="1">
<location>
<begin position="395"/>
<end position="400"/>
</location>
</feature>
<feature type="short sequence motif" description="LIR 10" evidence="1">
<location>
<begin position="411"/>
<end position="416"/>
</location>
</feature>
<feature type="short sequence motif" description="LIR 11" evidence="1">
<location>
<begin position="430"/>
<end position="435"/>
</location>
</feature>
<feature type="short sequence motif" description="LIR 12" evidence="1">
<location>
<begin position="486"/>
<end position="491"/>
</location>
</feature>
<feature type="short sequence motif" description="LIR 13" evidence="1">
<location>
<begin position="492"/>
<end position="497"/>
</location>
</feature>
<feature type="binding site" description="FAD; via amide nitrogen" evidence="1">
<location>
<position position="252"/>
</location>
</feature>
<feature type="binding site" description="FAD" evidence="1">
<location>
<position position="289"/>
</location>
</feature>
<feature type="binding site" description="FAD" evidence="1">
<location>
<position position="355"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by AMPK" evidence="1">
<location>
<position position="71"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by MAPK" evidence="1">
<location>
<position position="247"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by AMPK" evidence="1">
<location>
<position position="280"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="1">
<location>
<position position="568"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="1">
<location>
<position position="11"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="1">
<location>
<position position="107"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="1">
<location>
<position position="159"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="1">
<location>
<position position="329"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="1">
<location>
<position position="485"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="1">
<location>
<position position="565"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of binding to KL001." evidence="9">
<original>D</original>
<variation>N</variation>
<location>
<position position="387"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of binding to KL001." evidence="9">
<original>N</original>
<variation>D</variation>
<location>
<position position="393"/>
</location>
</feature>
<evidence key="1" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P97784"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10531061"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14672706"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16790549"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17463251"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20852621"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21613214"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22170608"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22798407"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23133559"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26431207"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27565346"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28388406"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="30530698"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000305"/>
<sequence length="586" mass="66395" checksum="96A5B09A6364D3B9" modified="1996-11-01" version="1">MGVNAVHWFRKGLRLHDNPALKECIQGADTIRCVYILDPWFAGSSNVGINRWRFLLQCLEDLDANLRKLNSRLFVIRGQPADVFPRLFKEWNITKLSIEYDSEPFGKERDAAIKKLATEAGVEVIVRISHTLYDLDKIIELNGGQPPLTYKRFQTLISKMEPLEIPVETITSEVIEKCTTPLSDDHDEKYGVPSLEELGFDTDGLSSAVWPGGETEALTRLERHLERKAWVANFERPRMNANSLLASPTGLSPYLRFGCLSCRLFYFKLTDLYKKVKKNSSPPLSLYGQLLWREFFYTAATNNPRFDKMEGNPICVQIPWDKNPEALAKWAEGRTGFPWIDAIMTQLRQEGWIHHLARHAVACFLTRGDLWISWEEGMKVFEELLLDADWSINAGSWMWLSCSSFFQQFFHCYCPVGFGRRTDPNGDYIRRYLPVLRGFPAKYIYDPWNAPEGIQKVAKCLIGVNYPKPMVNHAEASRLNIERMKQIYQQLSRYRGLGLLASVPSNPNGNGGFMGYSAENIPGCSSSGSCSQGSGILHYAHGDSQQTHLLKQGRSSMGTGLSGGKRPSQEEDTQSIGPKVQRQSTN</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

